Evaluation of oncologic outcomes in head and neck cancer patients ≥80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment-Reference-Cited by-同舟云学术

Evaluation of oncologic outcomes in head and neck cancer patients ≥80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment

Published:2019-09-12 Issue:12 Volume:41 Page:4128-4135
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Roden Dylan¹,Daniels Kelly¹^ORCID,Metkus James¹,Goldman Richard¹,Walsh Amanda¹,Johnson Jennifer²,Hamilton James¹,Keane William¹,Chapman Andrew²,Bar‐Ad Voichita³,Sweeny Larissa⁴,Curry Joseph¹,Cognetti David¹^ORCID,Luginbuhl Adam¹

Affiliation:

1. Department of OtolaryngologyThomas Jefferson University Philadelphia Pennsylvania

2. Department of Medical OncologyThomas Jefferson University Philadelphia Pennsylvania

3. Department of Radiation OncologyThomas Jefferson University Philadelphia Pennsylvania

4. Department of OtolaryngologyLouisiana State University Health and Science Center New Orleans Louisiana

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.25950

Reference28 articles.

1. Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

2. Octogenarian Free Flap Reconstruction: Complications and Cost of Therapy

3. Efficacy of Free Flap Reconstruction of the Head and Neck in Patients 90 Years and Older

4. Polypharmacy in Older Adults with Cancer

5. Immune System Dysfunction in the Elderly

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment outcome of elderly patients (≥ 78 years) with head and neck squamous cell carcinoma: A single center experience;Biomolecules and Biomedicine;2024-09-06

2. Treatment with (chemo)-radiation in old patients (≥76 years of age) with newly diagnosed non-metastatic squamous cell cancer of the head and neck region: real-world data from a tertiary referral center;Frontiers in Oncology;2024-04-25

3. Patterns and Trends in Adjuvant Therapy for Major Salivary Gland Cancer;Otolaryngology–Head and Neck Surgery;2024-03-14

4. Guideline-compliant adjuvant chemotherapy for resected high risk oral cavity cancer: Homefield advantage;American Journal of Otolaryngology;2024-01

5. Clinical predictors of premature radiotherapy terminations in senior adults with oral cavity and laryngeal carcinoma;Head & Neck;2023-11-11